Company Data

Spruce Biosciences Inc.

Ticker
SPRB
Current Price
$0.4081 0.64%
Market Cap
$16.9M
Price Target
Refer to Report
Volume
344.7K
52wk Range
$0.3421 - $5.95
Advanced Market Data

Overview

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy